{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T23:23:35Z","timestamp":1791501815902,"version":"4.3.4"},"reference-count":49,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,6,20]],"date-time":"2019-06-20T00:00:00Z","timestamp":1560988800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006315","name":"ReumaNederland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006315","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2019.01335","type":"journal-article","created":{"date-parts":[[2019,6,20]],"date-time":"2019-06-20T08:37:55Z","timestamp":1561019875000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":21,"title":["MicroRNA-130a Contributes to Type-2 Classical DC-activation in Sj\u00f6gren's Syndrome by Targeting Mitogen- and Stress-Activated Protein Kinase-1"],"prefix":"10.3389","volume":"10","author":[{"given":"Ana P.","family":"Lopes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel A. G.","family":"van Roon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofie L. M.","family":"Blokland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maojie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleni","family":"Chouri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarita A. Y.","family":"Hartgring","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim M. G.","family":"van der Wurff-Jacobs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aike A.","family":"Kruize","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boudewijn M. T.","family":"Burgering","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marzia","family":"Rossato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy R. D. J.","family":"Radstake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maarten R.","family":"Hillen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,6,20]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1002\/acr.21610","article-title":"Primary Sjogren's syndrome as a systemic disease: a study of participants enrolled in an international Sjogren's syndrome registry","volume":"64","author":"Malladi","year":"2012","journal-title":"Arthritis Care Res."},{"key":"B2","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.clim.2017.04.003","article-title":"Innate immunity in Sjogren's syndrome","volume":"182","author":"Kiripolsky","year":"2017","journal-title":"Clin Immunol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.pharmthera.2017.10.019","article-title":"Cytokines as therapeutic targets in primary Sjogren syndrome","volume":"184","author":"Retamozo","year":"2018","journal-title":"Pharmacol Ther."},{"key":"B4","doi-asserted-by":"publisher","first-page":"16047","DOI":"10.1038\/nrdp.2016.48","article-title":"Sjogren syndrome","volume":"2","author":"Brito-Zeron","year":"2016","journal-title":"Nat Rev Dis Primers."},{"key":"B5","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/imm.12888","article-title":"Human dendritic cell subsets: an update","volume":"154","author":"Collin","year":"2018","journal-title":"Immunology."},{"key":"B6","doi-asserted-by":"publisher","first-page":"131","DOI":"10.3389\/fimmu.2014.00131","article-title":"Human dendritic cell functional specialization in steady-state and inflammation","volume":"5","author":"Boltjes","year":"2014","journal-title":"Front Immunol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"3605643","DOI":"10.1155\/2016\/3605643","article-title":"A comparative study of the T cell stimulatory and polarizing capacity of human primary blood dendritic cell subsets","volume":"2016","author":"Sittig","year":"2016","journal-title":"Mediators Inflamm."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1002\/eji.201546136","article-title":"IL-10 promotes homeostatic proliferation of human CD8(+) memory T cells and, when produced by CD1c(+) DCs, shapes naive CD8(+) T-cell priming","volume":"46","author":"Nizzoli","year":"2016","journal-title":"Eur J Immunol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1111\/j.1365-2249.2009.04071.x","article-title":"Decrease of blood dendritic cells and increase of tissue-infiltrating dendritic cells are involved in the induction of Sjogren's syndrome but not in the maintenance","volume":"159","author":"Ozaki","year":"2010","journal-title":"Clin Exp Immunol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1002\/1529-0131(200102)44:2<419::AID-ANR61>3.3.CO;2-L","article-title":"Alteration of peripheral blood dendritic cells in patients with primary Sjogren's syndrome","volume":"44","author":"Ozaki","year":"2001","journal-title":"Arthritis Rheum."},{"key":"B11","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1586\/1744666X.2014.878650","article-title":"Dendritic cells, T-cells and epithelial cells: a crucial interplay in immunopathology of primary Sjogren's syndrome","volume":"10","author":"Hillen","year":"2014","journal-title":"Expert Rev Clin Immunol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.imlet.2011.06.007","article-title":"The complexity of Sjogren's syndrome: novel aspects on pathogenesis","volume":"141","author":"Jonsson","year":"2011","journal-title":"Immunol Lett."},{"key":"B13","doi-asserted-by":"publisher","first-page":"970607","DOI":"10.1155\/2014\/970607","article-title":"Mechanisms of miRNA-mediated gene regulation from common downregulation to mRNA-specific upregulation","volume":"2014","author":"Valinezhad Orang","year":"2014","journal-title":"Int J Genomics."},{"key":"B14","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1038\/nrd4359","article-title":"Therapeutic targeting of microRNAs: current status and future challenges","volume":"13","author":"Li","year":"2014","journal-title":"Nat Rev Drug Discov."},{"key":"B15","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.proghi.2016.06.001","article-title":"Intracellular and extracellular microRNA: an update on localization and biological role","volume":"51","author":"Makarova","year":"2016","journal-title":"Prog Histochem Cytochem."},{"key":"B16","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1136\/annrheumdis-2017-211417","article-title":"Deregulation of microRNA expression in purified T and B lymphocytes from patients with primary Sjogren's syndrome","volume":"77","author":"Wang-Renault","year":"2018","journal-title":"Ann Rheum Dis."},{"key":"B17","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1111\/jop.12187","article-title":"miR-146a and miR-155 expression in PBMCs from patients with Sjogren's syndrome","volume":"43","author":"Shi","year":"2014","journal-title":"J Oral Pathol Med."},{"key":"B18","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1002\/art.30131","article-title":"MicroRNA expression profiles as biomarkers of minor salivary gland inflammation and dysfunction in Sjogren's syndrome","volume":"63","author":"Alevizos","year":"2011","journal-title":"Arthritis Rheum."},{"key":"B19","doi-asserted-by":"publisher","first-page":"7510174","DOI":"10.1155\/2018\/7510174","article-title":"MicroRNA in Sjogren's syndrome: their potential roles in pathogenesis and diagnosis","volume":"2018","author":"Reale","year":"2018","journal-title":"J Immunol Res."},{"key":"B20","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.jaut.2011.05.003","article-title":"Cellular microRNAs (miRNAs) and Sjogren's syndrome: candidate regulators of autoimmune response and autoantigen expression","volume":"37","author":"Kapsogeorgou","year":"2011","journal-title":"J Autoimmun."},{"key":"B21","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1111\/cei.12664","article-title":"Study of microRNAs (miRNAs) that are predicted to target the autoantigens Ro\/SSA and La\/SSB in primary Sjogren's syndrome","volume":"182","author":"Gourzi","year":"2015","journal-title":"Clin Exp Immunol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1136\/annrheumdis-2017-212639","article-title":"Low miR200b-5p levels in minor salivary glands: a novel molecular marker predicting lymphoma development in patients with Sjogren's syndrome","volume":"77","author":"Kapsogeorgou","year":"2018","journal-title":"Ann Rheum Dis."},{"key":"B23","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1136\/ard.61.6.554","article-title":"Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group","volume":"61","author":"Vitali","year":"2002","journal-title":"Ann Rheum Dis."},{"key":"B24","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.jaut.2017.12.015","article-title":"Serum microRNA screening and functional studies reveal miR-483\u20135p as a potential driver of fibrosis in systemic sclerosis","volume":"89","author":"Chouri","year":"2018","journal-title":"J Autoimmun."},{"key":"B25","doi-asserted-by":"publisher","first-page":"e0193157","DOI":"10.1371\/journal.pone.0193157","article-title":"Circulating small non-coding RNAs reflect IFN status and B cell hyperactivity in patients with primary Sjogren's syndrome","volume":"13","author":"Lopes","year":"2018","journal-title":"PLoS ONE."},{"key":"B26","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1111\/imm.12390","article-title":"MicroRNAs affect dendritic cell function and phenotype","volume":"144","author":"Smyth","year":"2015","journal-title":"Immunology."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1246818","DOI":"10.1155\/2018\/1246818","article-title":"Current and emerging evidence for toll-like receptor activation in Sjogren's syndrome","volume":"2018","author":"Kiripolsky","year":"2018","journal-title":"J Immunol Res."},{"key":"B28","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1111\/cei.13077","article-title":"Activation of plasmacytoid dendritic cells by apoptotic particles - mechanism for the loss of immunological tolerance in Sjogren's syndrome","volume":"191","author":"Ainola","year":"2018","journal-title":"Clin Exp Immunol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"101","DOI":"10.3390\/genes4020101","article-title":"The role of mitogen-activated protein kinase-activated protein kinases (MAPKAPKs) in inflammation","volume":"4","author":"Moens","year":"2013","journal-title":"Genes."},{"key":"B30","doi-asserted-by":"publisher","first-page":"28017","DOI":"10.1074\/jbc.M112.383380","article-title":"Dimethyl fumarate inhibits dendritic cell maturation via nuclear factor kappaB (NF-kappaB) and extracellular signal-regulated kinase 1 and 2 (ERK1\/2) and mitogen stress-activated kinase 1 (MSK1) signaling","volume":"287","author":"Peng","year":"2012","journal-title":"J Biol Chem."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1038\/ni.1644","article-title":"The kinases MSK1 and MSK2 act as negative regulators of toll-like receptor signaling","volume":"9","author":"Ananieva","year":"2008","journal-title":"Nat Immunol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1042\/BJ20110970","article-title":"Characterization of the cellular action of the MSK inhibitor SB-747651A","volume":"441","author":"Naqvi","year":"2012","journal-title":"Biochem J."},{"key":"B33","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1111\/j.1365-2249.2006.03311.x","article-title":"Expression of functional toll-like receptors by salivary gland epithelial cells: increased mRNA expression in cells derived from patients with primary Sjogren's syndrome","volume":"147","author":"Spachidou","year":"2007","journal-title":"Clin Exp Immunol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1111\/sji.12520","article-title":"Expression of toll-like receptors in peripheral blood mononuclear cells of patients with primary Sjogren's syndrome","volume":"85","author":"Karlsen","year":"2017","journal-title":"Scand J Immunol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1136\/annrheumdis-2016-209589","article-title":"Contrasting expression pattern of RNA-sensing receptors TLR7, RIG-I and MDA5 in interferon-positive and interferon-negative patients with primary Sjogren's syndrome","volume":"76","author":"Maria","year":"2017","journal-title":"Ann Rheum Dis."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1002\/ijc.29491","article-title":"Epigenetic silencing of miR-708 enhances NF-kappaB signaling in chronic lymphocytic leukemia","volume":"137","author":"Baer","year":"2015","journal-title":"Int J Cancer."},{"key":"B37","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1186\/1479-5876-12-155","article-title":"NF-kappaB-modulated miR-130a targets TNF-alpha in cervical cancer cells","volume":"12","author":"Zhang","year":"2014","journal-title":"J Transl Med."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1093\/emboj\/cdg139","article-title":"Transcriptional activation of the NF-kappaB p65 subunit by mitogen- and stress-activated protein kinase-1 (MSK1)","volume":"22","author":"Vermeulen","year":"2003","journal-title":"EMBO J."},{"key":"B39","doi-asserted-by":"publisher","first-page":"17023","DOI":"10.1038\/sigtrans.2017.23","article-title":"NF-kappaB signaling in inflammation","volume":"2","author":"Liu","year":"2017","journal-title":"Signal Transduct Target Ther."},{"key":"B40","doi-asserted-by":"publisher","first-page":"5678046","DOI":"10.1155\/2016\/5678046","article-title":"TLR Signalling pathways diverge in their ability to induce PGE2","volume":"2016","author":"Salvi","year":"2016","journal-title":"Mediators Inflamm."},{"key":"B41","first-page":"970","article-title":"Salivary cytokine profiles in primary Sjogren's syndrome differ from those in non-Sjogren sicca in terms of TNF-alpha levels and Th-1\/Th-2 ratios","volume":"29","author":"Kang","year":"2011","journal-title":"Clin Exp Rheumatol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.jaci.2017.07.041","article-title":"Role of the IL-12\/IL-35 balance in patients with Sjogren syndrome","volume":"142","author":"Fogel","year":"2018","journal-title":"J Allergy Clin Immunol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"3633","DOI":"10.1002\/art.24980","article-title":"Interleukin-12 induces salivary gland dysfunction in transgenic mice, providing a new model of Sjogren's syndrome","volume":"60","author":"Vosters","year":"2009","journal-title":"Arthritis Rheum."},{"key":"B44","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1186\/ar3348","article-title":"Disturbance of cytokine networks in Sjogren's syndrome","volume":"13","author":"Youinou","year":"2011","journal-title":"Arthritis Res Ther."},{"key":"B45","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1067\/mlc.2002.120648","article-title":"Regulation of apoptotic cell death by cytokines in a human salivary gland cell line: distinct and synergistic mechanisms in apoptosis induced by tumor necrosis factor alpha and interferon gamma","volume":"139","author":"Kamachi","year":"2002","journal-title":"J Lab Clin Med."},{"key":"B46","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1136\/annrheumdis-2016-209952","article-title":"Influence of geolocation and ethnicity on the phenotypic expression of primary Sjogren's syndrome at diagnosis in 8310 patients: a cross-sectional study from the big data Sjogren project consortium","volume":"76","author":"Brito-Zeron","year":"2016","journal-title":"Ann Rheum Dis."},{"key":"B47","doi-asserted-by":"publisher","first-page":"3919","DOI":"10.4049\/jimmunol.1000296","article-title":"A versatile role of mammalian target of rapamycin in human dendritic cell function and differentiation","volume":"185","author":"Haidinger","year":"2010","journal-title":"J Immunol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.intimp.2016.04.028","article-title":"Pharmacological inhibition of PI3K class III enhances the production of pro- and anti-inflammatory cytokines in dendritic cells stimulated by TLR agonists","volume":"36","author":"Pittini","year":"2016","journal-title":"Int Immunopharmacol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.1038\/sj.jid.5700252","article-title":"Mitogen- and stress-activated protein kinase 1 is activated in lesional psoriatic epidermis and regulates the expression of pro-inflammatory cytokines","volume":"126","author":"Funding","year":"2006","journal-title":"J Invest Dermatol."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.01335\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,23]],"date-time":"2019-09-23T09:37:23Z","timestamp":1569231443000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.01335\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,20]]},"references-count":49,"alternative-id":["10.3389\/fimmu.2019.01335"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2019.01335","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,20]]},"article-number":"1335"}}